Cargando…
Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3
Recovery from alopecia is rare in autoimmune polyglandular syndrome (APS). A 41-year-old male was admitted to our hospital with hyperglycemia. He developed alopecia areata (AA) 5 months before admission and developed thirst, polyuria, and anorexia in 2 weeks. His plasma glucose level upon admission...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342500/ https://www.ncbi.nlm.nih.gov/pubmed/25759758 http://dx.doi.org/10.1530/EDM-14-0084 |
_version_ | 1782359280944414720 |
---|---|
author | Makino, Shinya Uchihashi, Takeshi Kataoka, Yasuo Fujiwara, Masayoshi |
author_facet | Makino, Shinya Uchihashi, Takeshi Kataoka, Yasuo Fujiwara, Masayoshi |
author_sort | Makino, Shinya |
collection | PubMed |
description | Recovery from alopecia is rare in autoimmune polyglandular syndrome (APS). A 41-year-old male was admitted to our hospital with hyperglycemia. He developed alopecia areata (AA) 5 months before admission and developed thirst, polyuria, and anorexia in 2 weeks. His plasma glucose level upon admission was 912 mg/dl (50.63 mmol/l) and HbA1c was 13.7%. Although urinary and plasma C-peptide levels showed that insulin secretion was not depleted, anti-insulinoma-associated antigen 2 antibody was present. In addition, measurement of thyroid autoantibodies revealed the presence of Hashimoto's thyroiditis. These findings suggested a diagnosis of APS type 3. The patient has showed signs of improvement with the continuation of insulin therapy. During the successful control of diabetes, he had total hair regrowth within 2–3 months. Human leukocyte antigen typing showed that DRB1*1501-DQB1*0602 and DQB1*0301 were present. Similar cases should be accumulated to clarify the association of APS type 3 with recovery from AA. LEARNING POINTS: Alopecia in diabetic patients is a suspicious manifestation of autoimmune type 1 diabetes. Patients with autoimmune type 1 diabetes specifically manifesting alopecia should be further examined for diagnosis of APS. Insulin-mediated metabolic improvement may be a factor, but not the sole factor, determining a favorable outcome of alopecia in patients with autoimmune type 1 diabetes. |
format | Online Article Text |
id | pubmed-4342500 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Bioscientifica Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-43425002015-03-10 Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3 Makino, Shinya Uchihashi, Takeshi Kataoka, Yasuo Fujiwara, Masayoshi Endocrinol Diabetes Metab Case Rep Unique/Unexpected Symptoms or Presentations of a Disease Recovery from alopecia is rare in autoimmune polyglandular syndrome (APS). A 41-year-old male was admitted to our hospital with hyperglycemia. He developed alopecia areata (AA) 5 months before admission and developed thirst, polyuria, and anorexia in 2 weeks. His plasma glucose level upon admission was 912 mg/dl (50.63 mmol/l) and HbA1c was 13.7%. Although urinary and plasma C-peptide levels showed that insulin secretion was not depleted, anti-insulinoma-associated antigen 2 antibody was present. In addition, measurement of thyroid autoantibodies revealed the presence of Hashimoto's thyroiditis. These findings suggested a diagnosis of APS type 3. The patient has showed signs of improvement with the continuation of insulin therapy. During the successful control of diabetes, he had total hair regrowth within 2–3 months. Human leukocyte antigen typing showed that DRB1*1501-DQB1*0602 and DQB1*0301 were present. Similar cases should be accumulated to clarify the association of APS type 3 with recovery from AA. LEARNING POINTS: Alopecia in diabetic patients is a suspicious manifestation of autoimmune type 1 diabetes. Patients with autoimmune type 1 diabetes specifically manifesting alopecia should be further examined for diagnosis of APS. Insulin-mediated metabolic improvement may be a factor, but not the sole factor, determining a favorable outcome of alopecia in patients with autoimmune type 1 diabetes. Bioscientifica Ltd 2015-02-01 2015 /pmc/articles/PMC4342500/ /pubmed/25759758 http://dx.doi.org/10.1530/EDM-14-0084 Text en © 2015 The authors This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License (http://creativecommons.org/licenses/by/3.0/deed.en_GB) . |
spellingShingle | Unique/Unexpected Symptoms or Presentations of a Disease Makino, Shinya Uchihashi, Takeshi Kataoka, Yasuo Fujiwara, Masayoshi Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3 |
title | Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3 |
title_full | Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3 |
title_fullStr | Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3 |
title_full_unstemmed | Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3 |
title_short | Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3 |
title_sort | recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3 |
topic | Unique/Unexpected Symptoms or Presentations of a Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342500/ https://www.ncbi.nlm.nih.gov/pubmed/25759758 http://dx.doi.org/10.1530/EDM-14-0084 |
work_keys_str_mv | AT makinoshinya recoveryfromalopeciaareatainapatientwithautoimmunepolyglandularsyndrometype3 AT uchihashitakeshi recoveryfromalopeciaareatainapatientwithautoimmunepolyglandularsyndrometype3 AT kataokayasuo recoveryfromalopeciaareatainapatientwithautoimmunepolyglandularsyndrometype3 AT fujiwaramasayoshi recoveryfromalopeciaareatainapatientwithautoimmunepolyglandularsyndrometype3 |